VIGENON
ActiveSummary
The computed 12-month bankruptcy probability of VIGENON is 3.5% (moderate). The 2025 annual accounts show negative equity (-€323,397) and a net result of -€38,197. Equity is shrinking by about 9.3% per year across the filed financial years. Its solvency ranks better than 5% of 22,513 sector peers (NACE 47, financial year 2025). The company has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals.
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- VIGENON
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Oprichting of opheffing van administratieve zetels,agentschappen,ateliers,opslagplaatsen,bijhuizen en exploitatiezetels bij enkel besluit…” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- Each director alone
- Board ruleHow the board is made up, meets and takes decisions.
- “Algemene vergadering die bestuurder(s) benoemt bepaalt aantal,duur van opdracht en,indien meerdere bestuurders,bevoegdheid, benoemd met of…” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- 31 May at 15:00